Susannah C Hahn, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1454 Baltimore Annapolis Blvd, Arnold, MD 21012 Phone: 410-626-8982 |
Ms. Joanne Patsynski Hasman, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1454 Baltimore Annapolis Blvd, Arnold, MD 21012 Phone: 410-626-8982 Fax: 410-626-8805 |
Mrs. Cassandra Burrell, MS, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1454 Baltimore Annapolis Blvd, Arnold, MD 21012 Phone: 410-626-8982 |
Ms. Jessica Blythe Linzmeier, MSN CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1454 Baltimore Annapolis Blvd, Arnold, MD 21012 Phone: 410-626-8982 |
Sandra Darko-williams, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1454 Baltimore Annapolis Blvd, Arnold, MD 21012 Phone: 410-626-8982 |
Linda Levinson, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1454 Baltimore Annapolis Blvd, Arnold, MD 21012 Phone: 410-626-8982 |
Miss Kathy S Mercer, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1454 Baltimore Annapolis Blvd, Arnold, MD 21012 Phone: 410-626-8982 |
News Archive
A leading expert on alcohol abuse has expressed concern about the lack of research about home drinking. Dr John Foster from the University of Greenwich is the first UK researcher to review all the research available about the drinking of alcohol by adults at home.
Alzheimer's Research UK is calling for urgent investment in dementia research, following new statistics that show the condition accounted for 13% of all UK deaths last year. The figures were released by the Office for National Statistics today (Wednesday 18 July).
Researchers in the laboratory of Dr. Jayakrishna Ambati at the University of Kentucky have discovered the first naturally occurring molecule that selectively blocks lymphatic vessel growth. In an article in the Aug. 9, 2009 online edition of Nature Medicine, they report the identification of a new molecule known as soluble VEGFR-2 that blocks lymphangiogenesis - the growth of lymphatics - but not blood vessel growth.
Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that it has filed a request for an FDA meeting to advance the URG101 clinical program and mutually agreed with Oceana Therapeutics, Inc. to terminate their Consulting Agreement effective immediately.
Australia has one of the lowest smoking rates in the world at 15 per cent of the population but there remains a need to further cut rates in prisons, among the mentally ill and ethnic communities, researchers will argue at a public health symposium in Sydney.
› Verified 1 days ago